Elizabeth S. Dorn
About Elizabeth S. Dorn
Elizabeth S. Dorn is the Sr. Medical Director of Medical Affairs at Alkermes, with a background in medical strategy and oncology product launches. She holds a PhD in molecular biology from the University of North Carolina at Chapel Hill.
Company
Elizabeth S. Dorn is currently working at Alkermes as the Sr. Medical Director of Medical Affairs. Alkermes is a biopharmaceutical company known for its development of innovative medicines in the fields of neuroscience and oncology. Elizabeth has been instrumental in leading medical strategy efforts, including the launch of oncology products.
Title
Elizabeth holds the title of Sr. Medical Director of Medical Affairs at Alkermes. In this role, she is responsible for driving medical strategies, collaborating with external advisors, and providing medical guidance to commercial teams in the oncology therapeutic area.
Education and Expertise
Elizabeth S. Dorn earned her Ph.D. in Biochemistry & Biophysics from the University of North Carolina at Chapel Hill, where she conducted significant research focused on rare diseases, oncology, and infectious diseases. She also holds a B.S. in Genetics from the University of Wisconsin-Madison. Her academic background underpins her extensive experience in medical affairs and strategic roles across biopharmaceutical companies.
Professional Background
Elizabeth's career trajectory includes numerous roles at Vertex Pharmaceuticals, where she worked in various capacities such as Medical Director of Medical Affairs and Senior Manager of Therapeutic Areas and Support. Her earlier career includes positions at Cell Microsystems and the University of North Carolina at Chapel Hill's Office of Technology Development. She also served as a Pharmacology Instructor at Duke University and an Editor at American Journal Experts.
Achievements
During her tenure at Alkermes, Elizabeth led the medical strategy for multiple oncology product launches. Her work involves extensive collaboration with external advisors and building consensus among partners to achieve strategic goals in medical affairs. Her role often requires managing high-pressure environments and working with both US and global partners, leveraging her comprehensive experience and expertise in the field.